[{"arm_notes": "", "treatment_id": null, "treatment_name": "Upon entry into the study (screening visit); each patient will be allocated to a Subject Identifier (Subject ID) number. This will be a 6 digit number where the first 3 digits identify the study center and the last 3 digits; which increase incrementally; will identify each subject at a given study center. The subject ID will be retained throughout the study and will be used to uniquely identify each patient. For patients eligible to receive study treatment; a randomization number will be allocated at the time of randomization. This randomization number will be used to identify and dispense the drug kits allocated to each subject. Note that the subject identifier number (Subject ID) which uniquely identifies the subject is different to the randomization number (uniquely identifies a drug kit). Patients will be randomized within each site to three groups: Group 1 (Experimental 1; n=40): Patients will continue the standard of care therapy (as per the Egyptian Ministry of Health [MOH] protocol) together with a daily oral dose of one gratisovir (sofosbuvir) 400 mg tablet combined with one ravidasvir 200 mg tablet orally [SOF+RVD] for 10 days; OR Group 2 (Experimental 2; n=40): Patients will continue the standard of care therapy (as per the Egyptian MOH protocol) together with a daily oral dose of one gratisovir (sofosbuvir) 400 mg tablet combined with one daktavera (daclatasvir) 60 mg tablet [SOF+DCV] for 10 days; OR Group 3 (Control; n=40): Patients will continue the standard of care therapy (as per the Egyptian MOH protocol) without any of the experimental drugs or other direct-acting antiviral therapy. The study duration will be as follows:", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1712, "treatment_name": "Ravidasvir+sofosbuvir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1478, "treatment_name": "Daclatasvir+sofosbuvir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]